Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT.
作者： Yasemin Sanli , Ishan Garg , Asha Kandathil , Tuba Kendi , Maria J. Baladron Zanetti
DOI: 10.2214/AJR.18.19881
关键词:
摘要: OBJECTIVE. The purpose of this article is to provide a review the use 68Ga tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, functional imaging modality for ass...
elsevier.com
sci-hub.se 参考文章(45)
Barbara Formisano, Massimo Milione, Marco Platania, Nicoletta Zilembo, Laura Catena, Emilio Bajetta, Monica Valente, Sara Pusceddu, Monika Ducceschi, Ettore Bichisao, Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms? Tumori. ,vol. 97, pp. 564- 567 ,(2011) , 10.1700/989.10712
Harshad R. Kulkarni, Vikas Prasad, Daniel Kaemmerer, Merten Hommann, Richard P. Baum, High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT. Recent results in cancer research. ,vol. 194, pp. 373- 378 ,(2013) , 10.1007/978-3-642-27994-2_19
D.R. Albanus, J. Apitzsch, Z. Erdem, O. Erdem, F.A. Verburg, F.F. Behrendt, F.M. Mottaghy, A. Heinzel, Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET) European Journal of Radiology. ,vol. 84, pp. 1866- 1872 ,(2015) , 10.1016/J.EJRAD.2015.06.024
Anders Sundin, Marie-Pierre Vullierme, Gregory Kaltsas, Ursula Plöckinger, ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations Neuroendocrinology. ,vol. 90, pp. 167- 183 ,(2009) , 10.1159/000184855
D. H. Simsek, S. Kuyumcu, C. Turkmen, Y. Sanl , F. Aykan, S. Unal, I. Adalet, Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors? The Journal of Nuclear Medicine. ,vol. 55, pp. 1811- 1817 ,(2014) , 10.2967/JNUMED.114.142224
Jean-Mathieu Beauregard, Michael S. Hofman, Grace Kong, Rodney J. Hicks, The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 39, pp. 50- 56 ,(2012) , 10.1007/S00259-011-1937-3
Olov Norlén, Peter Stålberg, Kjell Öberg, John Eriksson, Jakob Hedberg, Ola Hessman, Eva Tiensuu Janson, Per Hellman, Göran Åkerström, Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center World Journal of Surgery. ,vol. 36, pp. 1419- 1431 ,(2012) , 10.1007/S00268-011-1296-Z
Manu Shastry, Irfan Kayani, Damian Wild, Martyn Caplin, Dimitris Visvikis, Svetislav Gacinovic, Jean Claude Reubi, Jamshed B. Bomanji, Distribution pattern of 68Ga-DOTATATE in disease-free patients. Nuclear Medicine Communications. ,vol. 31, pp. 1025- 1032 ,(2010) , 10.1097/MNM.0B013E32833F635E
Dhakshinamoorthy Ganeshan, Erik Paulson, Cihan Duran, Maria E. Cabanillas, Naifa L. Busaidy, Chusilp Charnsangavej, Current update on medullary thyroid carcinoma American Journal of Roentgenology. ,vol. 201, ,(2013) , 10.2214/AJR.12.10370
M. Druckenthaner, C. Schwarzer, C. Ensinger, M. Gabriel, R. Prommegger, G. Riccabona, C. Decristoforo, Evidence for Somatostatin receptor 2 in thyroid tissue. Regulatory Peptides. ,vol. 138, pp. 32- 39 ,(2007) , 10.1016/J.REGPEP.2006.08.005